Nebivolol | List of Frontiers open access articles

Original Research

Published on 02 Aug 2017

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model

in Striated Muscle Physiology

Sabrina Stücker
Nico Kresin
Lucie Carrier
Felix W. Friedrich

Frontiers in Physiology

doi 10.3389/fphys.2017.00558

5,499 views
12 citations

Original Research

Published on 04 Aug 2022

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats

in Nephrology

Mariana Moura Nascimento
Desiree Rita Denelle Bernardo
Ana Carolina de Bragança
Maria Heloisa Massola Shimizu
Antonio Carlos Seguro
Rildo Aparecido Volpini
Daniele Canale

Frontiers in Medicine

doi 10.3389/fmed.2022.953749

5,019 views
10 citations

Original Research

Published on 06 Dec 2022

Screening of GPCR drugs for repurposing in breast cancer

in Experimental Pharmacology and Drug Discovery

Noor Mazin Abdulkareem
Raksha Bhat
Reid T. Powell
Soumya Chikermane
Soham Yande
Lisa Trinh
Hala Y. Abdelnasser
Mantasha Tabassum
Alexis Ruiz
Mary Sobieski

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049640

8,502 views
14 citations

Original Research

Published on 11 Jan 2021

The Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Sub-Saharan Africa (A Pilot Study)

in Hypertension

Dike Ojji
Boni Maxime Ale
Lamkur Shedul
Ejiroghene Umuerri
Emmanuel Ejim
Chizindu Alikor
Charles Agunyenwa
Uche Njideofor
Helen Eze
Victor Ansa

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.613917

6,849 views
3 citations

Original Research

Published on 31 Jan 2024

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Hongli Wang
Guizun Zhong
Huanhuan Ji
Siqi Chen
Qinqin Xie
Zhengze Shen
Yuntao Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1280201

6,148 views
8 citations

Original Research

Published on 12 Aug 2021

Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction

in Pharmacology of Anti-Cancer Drugs

Qian Chen
Han Jiang
Zhen Wang
Lu-Yao Cai
Yu-Chen Jiang
Liang Xie
Yu Zhou
Xin Zeng
Ning Ji
Ying-Qiang Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.691998

5,670 views
16 citations

Original Research

Published on 18 Sep 2025

Minoxidil and nebivolol restore aortic elastic fiber homeostasis in diabetic mice via potassium channel activation

in Vascular Physiology

Auberi Henry
Laetitia Vanalderwiert
Floriane Oszust
Amandine Wahart
Daniel A. Carvajal Berrio
Eva M. Brauchle
Katja Schenke-Layland
Juergen Brinckmann
Heiko Steenbock
Laurent Debelle

Frontiers in Physiology

doi 10.3389/fphys.2025.1648727

5,004 views

Original Research

Published on 09 Oct 2024

The β2-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent manner

in T Cell Biology

Mehri Hajiaghayi
Fatemeh Gholizadeh
Eric Han
Samuel R. Little
Niloufar Rahbari
Isabella Ardila
Carolina Lopez Naranjo
Kasra Tehranimeh
Steve C. C. Shih
Peter J. Darlington

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446424

5,156 views
3 citations

Systematic Review

Published on 11 Aug 2022

Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis

in Coronary Artery Disease

Dongsheng He
Jun Hu
Ying Li
Xiaofei Zeng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.968534

6,464 views
31 citations

Systematic Review

Published on 01 Apr 2026

Protective effects of beta-blockers against anthracycline- and trastuzumab-related cardiotoxicity: a systematic review based on conventional and Bayesian network meta-analysis

in Cardio-Oncology

Shenghao Jiang
Gan Gao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2026.1777908

638 views

Case Report

Published on 14 Apr 2026

Case Report: A reversible autonomic–endothelial migraine pattern: a conceptual perspective illustrated by a clinical case

in Headache

Vlodeks Gromakovskis

Frontiers in Pain Research

doi 10.3389/fpain.2026.1748356

1,149 views

Review

Published on 20 Dec 2024

β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress

in Experimental Pharmacology and Drug Discovery

Szymon Drygała
Michał Radzikowski
Mateusz Maciejczyk

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1489657

11,870 views
19 citations

Systematic Review

Published on 03 Sep 2025

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis

in Cardio-Oncology

Xiaoyu Liu
Ran Ding
Aihua Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1612060

3,144 views
1 citation

Original Research

Published on 08 Oct 2019

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database

in Drugs Outcomes Research and Policies

Maria Antonietta Barbieri
Giuseppe Cicala
Paola Maria Cutroneo
Eleonora Mocciaro
Laura Sottosanti
Francesco Freni
Francesco Galletti
Vincenzo Arcoraci
Edoardo Spina

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01161

41,839 views
37 citations

Articles

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats

Screening of GPCR drugs for repurposing in breast cancer

The Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Sub-Saharan Africa (A Pilot Study)

Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system

Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction

Minoxidil and nebivolol restore aortic elastic fiber homeostasis in diabetic mice via potassium channel activation

The β2-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent manner

Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis

Protective effects of beta-blockers against anthracycline- and trastuzumab-related cardiotoxicity: a systematic review based on conventional and Bayesian network meta-analysis

Case Report: A reversible autonomic–endothelial migraine pattern: a conceptual perspective illustrated by a clinical case

β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis

Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database